The European Medicines Agency (EMA) has validated the marketing authorisation application (MAA) submitted by Soleno ...

Tevimbra is currently approved in the EU as a treatment for gastric cancer, esophageal squamous cell cancer and small cell ...

The new infusion for maple syrup urine disease is for patients who cannot have an oral or enteral branched-chain amino ...

The antibiotic can no longer be used in moderate acne vulgaris, eradication of Helicobacter pylori, and prevention of ...

AstraZeneca (AZN) stock in focus as its antibody drug Imfinzi gains EU panel support for treating muscle-invasive bladder ...

The European Medicines Agency (EMA) has designated allopurinol as the first orphan drug for the treatment of Marfan syndrome, ...

The European drugs regulator said on Thursday its safety panel has confirmed suicidal thoughts as a side effect of anti-hair-loss drug finasteride and its generic versions, following an EU-wide review ...

Autolus' CAR-T cell therapy for a rare and aggressive form of acute lymphoblastic leukaemia (ALL), Aucatzyl, has been ...

EMA grants conditional marketing authorization to Autolus’ Aucatzyl to treat adults with acute lymphoblastic leukaemia: Amsterdam, The Netherlands Monday, May 26, 2025, 16:00 Hr ...

Company continues to advance QRX003 in late-stage clinical trials in Netherton Syndrome patients Regulatory milestone ...

The European Medicines Agency (EMA) published a workplan on its ambition to leverage high volumes of data and artificial intelligence (AI). On 7 ...

USD/JPY struggles to break above the 20-day Exponential Moving Average (EMA), which is currently around 144.45, indicating ...